Clinical trial Recruiting at 2 sites Interventional Ages 18 to 65

Prebiotic formulation and its effects on gut microbiota and body composition in adults

Official title: Evaluation of the Effects of the PI-YSP-0111 Formulation on Human Gut Microbiota and Body Composition

Run by Taipei Medical University · NCT07618000 · Data updated 2026-11-12

A prebiotic supplement (PI-YSP-0111) is being tested in healthy adults to see if 8 weeks of use can favorably change gut bacteria and body composition.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment140 (estimated)
SponsorTaipei Medical University
Academic / other
Locations2 sites (Taipei, Taiwan and 1 other locations)
StatusRecruiting
StartedApril 8, 2026
Main results expectedApril 7, 2027
Study endsApril 7, 2027
Registry record updatedJune 1, 2026
Trial IDNCT07618000 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy adults aged 18–65 with BMI 23.0–40.0 kg/m² and waist measurements meeting criteria, who are willing to maintain current lifestyle during the study.

Probably not a fit

Individuals with current gastrointestinal diseases, recent significant weight changes, or other specified health conditions may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study will compare high- and low-dose PI-YSP-0111 against placebo over 8 weeks in healthy adults aged 18–65. Participants will provide blood, urine, and fecal samples at baseline and after 8 weeks, with body composition and questionnaires assessed at baseline, 4 weeks, and 8 weeks. Data will be analyzed with a two-way mixed-design ANOVA to explore differences between and within groups. The trial is conducted at Taipei Medical University and Taipei Municipal WanFang Hospital in Taiwan, sponsored by Taipei Medical University with collaboration from Yung Shin Pharmaceutical Co., Ltd.

Why it matters

Potential benefit: If successful, participants may experience favorable changes in gut microbiota and liver-related health markers, along with body composition improvements.

How similar studies have gone: Prior research on prebiotic formulations has shown microbiota modulation and metabolic effects, though results vary by product and population, making this study's design exploratory for PI-YSP-0111.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Healthy males or females aged 18 to 65 years.
2. BMI between 23.0 and 40.0 kg/m².
3. Waist circumference: ≥ 90 cm for males and ≥ 80 cm for females.
4. Participants are willing to maintain their usual dietary habits, daily routines, and physical activity levels during the study period, and have no plans to relocate.
5. Participants have fully understood the study procedures and have signed the informed consent form.

Exclusion Criteria:

1. Presence of gastrointestinal diseases, such as inflammatory bowel disease, irritable bowel syndrome, gastroesophageal reflux disease, Crohn's disease, or a history of bariatric surgery.
2. Recent history of acute gastroenteritis, constipation or diarrhea; psychiatric disorders (e.g., depression or schizophrenia); cardiovascular diseases (e.g., hypertension); known allergy or hypersensitivity to the investigational product; extreme dietary habits; significant body weight change (\>4.5 kg) within the past three months; recent use of antibiotics or antifungal agents; or use of medications affecting gastrointestinal function (such as probiotics, laxatives, or nonsteroidal anti-inflammatory drugs \[NSAIDs\]).
3. Exposure to unapproved medications, alcohol abuse, or substance abuse.
4. Female-specific conditions, including significant gastrointestinal symptoms during menstruation, irregular menstrual cycles, pregnancy, planned pregnancy, or breastfeeding (participants who become pregnant during the study period will also be excluded).
5. Short-term use of corticosteroids, nonsteroidal anti-inflammatory drugs, immunosuppressive agents, interferons, or immunomodulatory agents within the past one month.
6. Use of any weight-loss medications (including oral agents, injections, or traditional Chinese medicine) within the past three months.
7. Participation in any other interventional clinical study within the past one month.
8. History of cancer or current malignancy within the past two years, except for non-melanoma skin cancer.
9. Occurrence of major trauma or any surgical procedures within the past one month.
10. History of diabetic ketoacidosis.

Where it's running

  • Taipei Medical University
    Taipei, Taiwan, Taiwan
    Recruiting
  • Taipei Municipal WanFang Hospital(Managed by Taipei Medical University)
    Taipei, Taiwan, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.